SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001789769-23-000090
Filing Date
2023-11-13
Accepted
2023-11-13 17:00:35
Documents
14
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K til-20231113.htm   iXBRL 8-K 33373
2 EX-99.1 q3-23er.htm EX-99.1 87211
6 LOGO imagea.jpg GRAPHIC 3565
  Complete submission text file 0001789769-23-000090.txt   268516

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20231113.xsd EX-101.SCH 1892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20231113_lab.xml EX-101.LAB 25850
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20231113_pre.xml EX-101.PRE 13576
8 EXTRACTED XBRL INSTANCE DOCUMENT til-20231113_htm.xml XML 3091
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

IRS No.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 231399842
SIC: 2836 Biological Products, (No Diagnostic Substances)